FDA Accepts NDA for Tiocystin by Casper Pharma
The FDA has accepted the New Drug Application (NDA) for Tiocystin (Tiopronin) submitted by Casper Pharma.
Asset / Drug
Drug and asset intelligence for Tiocystin with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.